Medicare Enrolled
Dr. Matthew Love, M.D.
Urology Physician · Fairfield, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Love from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Love?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Love
Dr. Matthew Love is an urology physician in Fairfield, OH, with 13 years of NPI registration. Based on federal Medicare data, Dr. Love performed 4,606 Medicare services across 1,319 unique beneficiaries.
Between the years covered by Open Payments, Dr. Love received a total of $28,565 from 40 pharmaceutical and/or device companies across 272 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Love is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 8% volume in OH
$28,565 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,606
Medicare services
Top 8% in OH for urology physician
1,319
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~354 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 2,750 | $2 | $9 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
505 | $3 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
502 | $90 | $249 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
72 | $8 | $53 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
70 | $54 | $624 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
64 | $8 | $32 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
60 | $67 | $468 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
53 | $7 | $94 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
52 | $23 | $311 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
52 | $8 | $39 |
| PSA test (prostate cancer screening) | 51 | $18 | $71 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
47 | $107 | $382 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
42 | $45 | $206 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
40 | $8 | $105 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
40 | $8 | $105 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
30 | $96 | $1,223 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
30 | $318 | $3,003 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $53 | $199 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
24 | $103 | $318 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
23 | $57 | $284 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
22 | $92 | $496 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
20 | $62 | $149 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
17 | $18 | $75 |
| Cystourethroscopy with ureteroscopy or pyeloscopy A diagnostic procedure using an endoscope to examine the bladder, urethra, and ureter or kidney. |
13 | $210 | $1,236 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
2.8% medium
95.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$28,565
Total received (2018-2024)
Avg $4,081/year across 7 years
Top 8% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
272
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$21,408 (74.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,933 (24.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$225 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$23,272
2023
$1,536
2022
$530
2021
$764
2020
$709
2019
$428
2018
$1,326
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Calyxo, Inc.
$21,408
Teleflex LLC
$1,267
Dendreon Pharmaceuticals LLC
$103
Bayer Healthcare Pharmaceuticals Inc.
$62
Astellas Pharma US Inc
$58
PFIZER INC.
$48
COLOPLAST CORP
$46
UROGEN PHARMA, INC.
$41
Axonics, Inc.
$33
Olympus America Inc.
$30
Merck Sharp & Dohme LLC
$29
Antares Pharma, Inc.
$24
Janssen Biotech, Inc.
$21
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
Ferring Pharmaceuticals Inc.
$18
IMMUNITYBIO, INC.
$16
Sumitomo Pharma America, Inc.
$16
Boston Scientific Corporation
$15
KARL STORZ Endoscopy-America
$15
Top 3 companies account for 97.9% of 2024 payments
All-time payments by company (2018-2024) ›
Calyxo, Inc.
$21,408
Teleflex LLC
$1,391
BOSTON SCIENTIFIC CORPORATION
$1,120
Janssen Biotech, Inc.
$752
Boston Scientific Corporation
$669
Astellas Pharma US Inc
$564
Coloplast Corp
$344
COLOPLAST CORP
$278
Dendreon Pharmaceuticals LLC
$220
TOLMAR Pharmaceuticals, Inc.
$164
NeoTract Inc.
$137
Axonics Modulation Technologies, Inc.
$136
Dornier MedTech America, Inc
$128
PFIZER INC.
$125
UroGen Pharma, Inc.
$86
Bayer Healthcare Pharmaceuticals Inc.
$78
Merck Sharp & Dohme LLC
$77
Medtronic, Inc.
$69
Sun Pharmaceutical Industries Inc.
$67
Olympus America Inc.
$62
UROVANT SCIENCES INC
$59
AbbVie Inc.
$58
UROGEN PHARMA, INC.
$56
AstraZeneca Pharmaceuticals LP
$52
Sumitomo Pharma America, Inc.
$48
ACCORD HEALTHCARE, INC.
$47
AbbVie, Inc.
$41
Myovant Sciences Inc.
$40
SUN PHARMACEUTICAL INDUSTRIES INC.
$37
Medtronic USA, Inc.
$35
Axonics, Inc.
$33
Merck Sharp & Dohme Corporation
$30
Bayer HealthCare Pharmaceuticals Inc.
$28
Amgen Inc.
$25
Antares Pharma, Inc.
$24
Ferring Pharmaceuticals Inc.
$18
IMMUNITYBIO, INC.
$16
KARL STORZ Endoscopy-America
$15
Egalet US Inc
$14
Kowa Pharmaceuticals America, Inc.
$13
Top 3 companies account for 83.7% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS · ANKTIVA · Axonics · Axonics r-SNM System · BRIDION · CAMCEVI · CONTINENCE CARE · CVAC ASPIRATION SYSTEM · Dornier MedTech · ELIGARD · ERLEADA · Erleada · GEMTESA · INTERSTIM · JELMYTO · KEYTRUDA · LITHOCLAST · LUPRON DEPOT · LYNPARZA · LithoVue · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · Nubeqa · ORGOVYX · Olympus Ultrasonic Devices · Olympus Ureteroscopes · PROVENGE · Prolia · Rezum Generator · SPEEDICATH · SPRIX · Seglentis · SpeediCath · TOVIAZ · UROLIFT · UroLift · XTANDI · XYOSTED · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (75%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 8% for urology physician in OH.
Geographic Context
Urology physicians within 10 mi
87
Per 100K population
22.3
County median income
$81,194
Nearest hospital
MERCY HEALTH - FAIRFIELD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Love is a mixed practice specialist, with above-average Medicare volume (top 8% in OH), with consulting-driven industry engagement in the top 8% of OH peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Love experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Love performed 2,750 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Love receive payments from pharmaceutical companies?
Yes. Dr. Love received a total of $28,565 from 40 companies across 272 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Love's costs compare to other urology physicians in Fairfield?
Dr. Love's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Love) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Fairfield
Browse urology physicians in Fairfield ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
Calyxo, Inc. Payments to Doctors
See all physicians who received payments from Calyxo, Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology